🔍 Observations
Topline
- Consolidated revenue surged 15.3% YoY (₹2,38,496 Cr → ₹2,74,944 Cr), with Q4FY26 alone jumping 20.4% YoY (₹64,890 Cr → ₹78,133 Cr) — broadest quarterly run-rate in recent history.
- Copper segment drove outsized topline contribution, growing 27.7% YoY (₹54,703 Cr → ₹69,838 Cr); Aluminium downstream accelerated 24.3% YoY (₹12,819 Cr → ₹15,938 Cr).
- Novelis, the largest segment at 59% of revenue, grew a modest 12.3% YoY (₹1,45,068 Cr → ₹1,62,882 Cr) — volume/mix, not commodity tailwinds, likely driving it.
Bottomline
- Reported PAT declined 16.3% YoY (₹16,002 Cr → ₹13,391 Cr), distorted entirely by exceptional charges of ₹6,963 Cr in FY26 vs. ₹879 Cr in FY25.
- Pre-exceptional PBT grew 9.7% YoY (₹23,216 Cr → ₹25,459 Cr), confirming underlying earnings power is intact and expanding.
- EPS (basic) compressed to ₹60.31 from ₹72.05 — optically weak, but exceptional-item-driven; core trajectory is positive.
Margins
- Segment EBITDA expanded to ₹37,217 Cr from ₹35,162 Cr (+5.8% YoY); consolidated EBITDA (segment results + unallocable, pre-finance/D&A) at ₹38,097 Cr vs. ₹35,496 Cr (+7.3% YoY).
- EBITDA margin on revenue from operations: 38,097 / 2,74,944 = 13.9% vs. 35,496 / 2,38,496 = 14.9% — 100 bps compression YoY, partly attributable to Copper’s lower-margin revenue mix growing fastest.
- Aluminium upstream segment result improved to ₹18,884 Cr from ₹16,262 Cr (+16.1% YoY) — the highest-margin segment delivering the best absolute growth.
Growth Trajectory
- Revenue CAGR implied over two years is healthy, but working capital consumption is accelerating disproportionately — a structural flag for FY27 free cash flow visibility.
- Aluminium downstream, though small, grew 54.5% in segment results (₹633 Cr → ₹978 Cr) — early signs of downstream value-add monetisation.
- Novelis segment result fell 4.6% YoY (₹15,242 Cr → ₹14,546 Cr) despite revenue growth — margin dilution at the most important subsidiary warrants monitoring.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Pre-exceptional PBT +9.7% YoY — core business earnings momentum is real, stripped of accounting noise from asset impairments.
- Aluminium upstream segment results +16.1% YoY — the highest-margin business is firing on volume and realisation simultaneously.
- Copper revenue +27.7% YoY — rapid scaling of a commodity-plus-value-chain segment diversifies revenue and reduces single-segment concentration.
- Cash and equivalents up 46.3% YoY (₹9,808 Cr → ₹14,350 Cr) — liquidity buffer strengthened despite elevated capex.
- D&A increasing (₹7,881 Cr → ₹8,830 Cr) reflects productive asset addition; capex of ₹30,096 Cr signals a management commitment to future capacity.
- Aluminium downstream segment EBIT near-doubled (₹633 Cr → ₹978 Cr) — value-added aluminium is gaining commercial traction.
- Q4FY26 sequential recovery sharp — revenue up 17.5% QoQ and segment results up 23.4% QoQ, suggesting exit-quarter momentum into FY27.
🔴 Red Flags
- Exceptional charges ₹6,963 Cr in FY26 vs. ₹879 Cr in FY25 — scale and recurrence suggest these are no longer truly exceptional; likely tied to Novelis restructuring costs.
- Inventory surge: ₹48,801 Cr → ₹75,517 Cr (+54.7% YoY) — ₹24,518 Cr working capital absorption in a single year is significant and compresses operating FCF severely.
- Operating cash flow collapsed to ₹10,250 Cr from ₹24,410 Cr — a 58% decline driven primarily by working capital build; not sustainable if inventory doesn’t monetise.
- Total borrowings jumped from ₹61,931 Cr to ₹96,659 Cr (non-current ₹56,217 Cr → ₹75,595 Cr; current ₹5,714 Cr → ₹21,064 Cr) — leverage is rising materially at a time of elevated capex.
- Novelis margin erosion — segment results fell 4.6% despite 12.3% revenue growth; if Novelis EBITDA per tonne is compressing, the re-rating thesis weakens.
- Current liabilities nearly doubled (₹65,516 Cr → ₹1,16,509 Cr) — trade payables alone up from ₹40,434 Cr to ₹61,624 Cr; financial derivative liabilities exploded from ₹1,022 Cr to ₹10,316 Cr.
- Capex at ₹30,096 Cr vs. OCF of ₹10,250 Cr — FCF deeply negative at approximately –₹19,846 Cr; entirely debt-funded expansion carries execution risk.
📊 Balance Sheet Analysis
- Asset base expanded sharply: Total assets grew from ₹2,65,991 Cr to ₹3,47,795 Cr (+30.8% YoY), largely from CWIP (₹27,023 Cr → ₹47,569 Cr) and inventory — both illiquid in the near term.
- Leverage elevated but equity base healthy: Debt-to-equity (total borrowings / total equity) at 96,659 / 1,36,595 = 0.71x vs. prior year 61,931 / 1,23,721 = 0.50x — meaningful deterioration in one year.
- Goodwill at ₹29,553 Cr (largely Novelis acquisition) remains a latent impairment risk; Novelis margin softness makes this a live watch-item.
- Equity grew organically (₹1,23,709 Cr → ₹1,36,583 Cr) via retained earnings — no dilution, which is credit-positive.
💰 Cash Flow Analysis
- OCF at ₹10,250 Cr (vs. ₹24,410 Cr) — operating profit before working capital was stable at ₹30,963 Cr; the ₹20,237 Cr net working capital outflow is the sole culprit.
- Investing outflow of ₹26,583 Cr driven by ₹30,096 Cr capex — Novelis’s ongoing capacity expansion and Indian upstream projects are absorbing capital at peak cycle pace.
- Financing inflows of ₹20,087 Cr plugged the FCF gap — net new borrowings (proceeds minus repayments) of approximately ₹28,193 Cr funded both capex and dividends.
- Free cash flow: ₹10,250 Cr – ₹30,096 Cr = –₹19,846 Cr — negative FCF for FY26 is a deliberate capital allocation choice, not distress, but FY27 delivery on capex returns is now non-negotiable.
💡 Investment Outlook
Hindalco’s core operating engine — particularly Aluminium upstream and Copper — is performing well, with pre-exceptional earnings growing nearly 10% on a 15% revenue jump.
However, FY26 has been a year of aggressive balance sheet deployment: debt is up ~56%, inventory has ballooned 55%, and FCF turned deeply negative — all bets on capex returns materialising in FY27–28.
The Novelis margin story is the swing factor; if adjusted EBITDA per tonne recovers as the new rolling capacity ramps, the investment case strengthens materially.
Investors should treat FY26 as a transition year and track Novelis EBITDA/tonne, inventory normalisation, and OCF recovery as the three leading indicators for re-rating.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.